132 related articles for article (PubMed ID: 15762218)
1. Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma.
Peris K; Ferrari A; Fargnoli MC; Piccolo D; Chimenti S
Dermatol Surg; 2005 Feb; 31(2):217-20. PubMed ID: 15762218
[No Abstract] [Full Text] [Related]
2. Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma.
Peris K; Fargnoli MC; Chimenti S
N Engl J Med; 1999 Dec; 341(23):1767-8. PubMed ID: 10610445
[No Abstract] [Full Text] [Related]
3. Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene.
Orlandi A; Bianchi L; Costanzo A; Campione E; Giusto Spagnoli L; Chimenti S
J Invest Dermatol; 2004 Apr; 122(4):1037-41. PubMed ID: 15102095
[TBL] [Abstract][Full Text] [Related]
4. Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases.
Bianchi L; Orlandi A; Campione E; Angeloni C; Costanzo A; Spagnoli LG; Chimenti S
Br J Dermatol; 2004 Jul; 151(1):148-56. PubMed ID: 15270884
[TBL] [Abstract][Full Text] [Related]
5. Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application.
Duvic M; Ni X; Talpur R; Herne K; Schulz C; Sui D; Ward S; Joseph A; Hazarika P
J Invest Dermatol; 2003 Oct; 121(4):902-9. PubMed ID: 14632211
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of Favre-Racouchot disease with 0.05% tazarotene gel.
Rallis E; Karanikola E; Verros C
Arch Dermatol; 2007 Jun; 143(6):810-2. PubMed ID: 17576962
[No Abstract] [Full Text] [Related]
7. Treatment of occupational koilonychia with tazarotene gel.
Hagman JH; Ginebri A; Mordenti C; De Simoni I; Chimenti S
Acta Derm Venereol; 2003; 83(4):296-7. PubMed ID: 12926806
[No Abstract] [Full Text] [Related]
8. Confluent and reticulate papillomatosis treated with minocycline and tazarotene.
Tseng HW; Tseng HH; Wu CS
Cutis; 2013 Apr; 91(4):194-7. PubMed ID: 23763080
[TBL] [Abstract][Full Text] [Related]
9. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
Lebwohl M; Ast E; Callen JP; Cullen SI; Hong SR; Kulp-Shorten CL; Lowe NJ; Phillips TJ; Rosen T; Wolf DI; Quell JM; Sefton J; Lue JC; Gibson JR; Chandraratna RA
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):705-11. PubMed ID: 9591815
[TBL] [Abstract][Full Text] [Related]
10. Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome.
Tang JY; Chiou AS; Mackay-Wiggan JM; Aszterbaum M; Chanana AM; Lee W; Lindgren JA; Raphael MA; Thompson BJ; Bickers DR; Epstein EH
Cancer Prev Res (Phila); 2014 Mar; 7(3):292-9. PubMed ID: 24441673
[TBL] [Abstract][Full Text] [Related]
11. A pilot study on the use of topical tazarotene to treat squamous cell carcinoma in situ.
Bardazzi F; Bianchi F; Parente G; Guareschi E; Landi C
J Am Acad Dermatol; 2005 Jun; 52(6):1102-4. PubMed ID: 15928641
[No Abstract] [Full Text] [Related]
12. Complete regression of keratoacanthoma with topical tazarotene gel 0.1%: therapeutic and pathophysiological perspectives.
Paolino G; Muscardin LM; Donati M; Didona D; Panetta C; Donati P
G Ital Dermatol Venereol; 2019 Apr; 154(2):220-221. PubMed ID: 28895378
[No Abstract] [Full Text] [Related]
13. Combination therapy with imiquimod, 5-fluorouracil, and tazarotene in the treatment of extensive radiation-induced Bowen's disease of the hands.
Modi G; Jacobs AA; Orengo IF; McClung A; Rosen T
Dermatol Surg; 2010 May; 36(5):694-700. PubMed ID: 19732103
[No Abstract] [Full Text] [Related]
14. Superficial basal cell carcinoma successfully treated with ingenol mebutate gel 0.05%.
Cantisani C; Paolino G; Cantoresi F; Faina V; Richetta AG; Calvieri S
Dermatol Ther; 2014; 27(6):352-4. PubMed ID: 25052730
[No Abstract] [Full Text] [Related]
15. Do lasers or topicals really work for nonmelanoma skin cancers?
Brightman L; Warycha M; Anolik R; Geronemus R
Semin Cutan Med Surg; 2011 Mar; 30(1):14-25. PubMed ID: 21540017
[TBL] [Abstract][Full Text] [Related]
16. Elephantiasis nostrum verrucosa of the abdomen: clinical results with tazarotene.
Boyd J; Sloan S; Meffert J
J Drugs Dermatol; 2004; 3(4):446-8. PubMed ID: 15303792
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of topical tazarotene in the treatment of mild to moderate acne.
Leyden JJ
Cutis; 2004 Oct; 74(4 Suppl):9-15. PubMed ID: 15543714
[TBL] [Abstract][Full Text] [Related]
18. An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and/or corticosteroid.
Tanghetti EA;
Cutis; 2000 Dec; 66(6 Suppl):4-11. PubMed ID: 11147088
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis.
Krueger GG; Drake LA; Elias PM; Lowe NJ; Guzzo C; Weinstein GD; Lew-Kaya DA; Lue JC; Sefton J; Chandraratna RA
Arch Dermatol; 1998 Jan; 134(1):57-60. PubMed ID: 9449910
[TBL] [Abstract][Full Text] [Related]
20. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
Webster GF; Guenther L; Poulin YP; Solomon BA; Loven K; Lee J
Cutis; 2002 Feb; 69(2 Suppl):4-11. PubMed ID: 12095066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
